首页> 外国专利> HUMANIZED MONOCLONAL ANTIBODIES THAT INHIBIT ENZYMATIC ACTIVITY OF VASCULAR ENDOTHELIAL LIPASE

HUMANIZED MONOCLONAL ANTIBODIES THAT INHIBIT ENZYMATIC ACTIVITY OF VASCULAR ENDOTHELIAL LIPASE

机译:抑制血管内皮脂肪酶酶活性的人源化单克隆抗体

摘要

To provide humanized monoclonal antibodies or antibody fragments thereof that selectively inhibit the enzymatic activity of endothelial lipase, or pharmaceutical compositions comprising the same.SOLUTION: Provided is an injection preparation comprising a humanized monoclonal antibody against endothelial lipase or a fragment thereof with specific binding ability to vascular endothelial lipase, where the antibody comprises a heavy chain variable region including specific amino acid sequences as CDR1, CDR2 and CDR3, and a light chain variable region including specific amino acid sequences as CDR1, CDR2 and CDR3.SELECTED DRAWING: None
机译:提供选择性抑制内皮脂肪酶酶活性的人源化单克隆抗体或其抗体片段,或包含该抗体的药物组合物。解决方案:本发明提供一种注射制剂,其包含针对内皮脂酶的人源化单克隆抗体或其片段具有特异性结合能力。血管内皮脂肪酶,其中抗体包含重链可变区和轻链可变区,重链可变区包括CDR1,CDR2和CDR3的特定氨基酸序列,轻链可变区包括CDR1,CDR2和CDR3的特定氨基酸序列。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号